Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models

Antibodies blocking the programmed death-ligand 1 (PD-L1) have shown impressive and durable responses in clinical studies. However, this type of immunotherapy is only effective in a subset of patients and not sufficient for rejection of all tumor types. In this study, we explored in two mouse tumor...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Heng Sheng Sow, Jiang Ren, Marcel Camps, Ferry Ossendorp, Peter ten Dijke
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2019-04-01
Serier:	Cells
Fag:	anti-PD-L1 mAb 1 LY364947 2 mouse syngeneic tumor models 3
Online adgang:	https://www.mdpi.com/2073-4409/8/4/320
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!